Status:
COMPLETED
Whole-body Electromyostimulation in Inpatient Rehabilitation
Lead Sponsor:
Prof. Dr. Frank Mooren
Conditions:
Sarcopenia
Eligibility:
All Genders
Phase:
NA
Brief Summary
Based on various studies, scientific evidence has proven the effectiveness of whole-body electromyostimulation (WB-EMS) on parameters such as increased physiological performance and body composition. ...
Detailed Description
The loss of muscle mass in the age-associated process (sarcopenia) is a common indication in the field of orthopedic and cardiac rehabilitation, which may also be reinforced by previous immobilization...
Eligibility Criteria
Inclusion
- skeletal muscle index (SMI) \< 0,789 (men); \< 0,512 (women)
- A general state of good health
- Medically approved unrestricted sports participation as shown by diagnostic performance test
- Willingness to provide signed informed consent
Exclusion
- Post-coronary artery bypass graft (ACVB) surgery in the last 3 months
- Condition after pacemaker and defibrillator implantation
- renal insufficiency from stage 3a
- epilepsy
- feverish diseases or infectious diseases
- Taking medicines the affect muscle metabolism
- severe neurological disorders
- Skin injuries in the area of electrodes
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2020
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT03767088
Start Date
January 1 2019
End Date
March 15 2020
Last Update
May 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik Königsfeld der DRV
Ennepetal, North Rhine-Westphalia, Germany, 58256